# Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

> **NCT02322619** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Moxifloxacin Tablets 400 mg

## Key facts

- **NCT ID:** NCT02322619
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322619, "Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02322619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*